CVE-2017-6527
What it is
An issue was discovered in dnaTools dnaLIMS 4-2015s13. dnaLIMS is vulnerable to a NUL-terminated directory traversal attack allowing an unauthenticated attacker to access system files readable by the web server user (by using the viewAppletFsa.cgi seqID parameter).
At a glance
- Exploitability
- Can be exploited over the network without logging in. High risk of data exposure.
- Exploit odds
- 56.6% chance of exploitation in the next 30 days (EPSS). Higher than most.
- Fix
- No patch or advisory is linked yet. Look at mitigations or restrict exposure.
Timeline
- PublishedDisclosed publicly on CVE.org and NVD
- Last updatedMost recent change to the record
Why it ranks here
- Exploited in the wild: no, CISA does not list it.
- Exploit odds: 56.6% in the next 30 days (EPSS).
- Severity: 7.5 HIGH (CVSS).
- Fix: none linked yet, which raises it.
Details
- Published
- Last modified
- Exploit probability
- 56.6% · EPSS, next 30 days
- Weakness
- CWE-22 · Path traversal
- Record status
- Modified
Affected
- Dnatools Dnalims 4-2015s13
Attack profile CVSS 3.0 · 7.5
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
- Scope
- Unchanged
- Confidentiality
- High
- Integrity
- None
- Availability
- None
Raw vector
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Is it in your code?
Hand this to your coding agent. It searches your project for the affected products and checks versions. Nothing leaves your machine.
Read https://cve-list.com/agent/cve/CVE-2017-6527.md and follow it. Check whether this project is affected by CVE-2017-6527. Read only. Don't change anything and don't upload my code. Tell me yes, no or not sure, with the file as proof.
References
- http://www.securityfocus.com/bid/96823
- https://www.exploit-db.com/exploits/41578/
- https://www.shorebreaksecurity.com/blog/product-security-advisory-psa0002-dnalims/
- http://www.securityfocus.com/bid/96823
- https://www.exploit-db.com/exploits/41578/
- https://www.shorebreaksecurity.com/blog/product-security-advisory-psa0002-dnalims/